Josh Riggs Oncocyte Corp (OCX) insider trading activity

OCX Quotes by TradingView

Josh Riggs is CEO and President of Oncocyte Corp. Currently has a direct ownership of 3,505 shares of OCX, which is worth approximately $7,675. The most recent transaction as insider was on Apr 11, 2024, when has been sold 3,390 shares (Common Stock, No Par Value) at a price of $2.95 per share, resulting in proceeds of $10,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.51K
0% 3M change
n/a 12M change
Total Value Held $7,675

Josh Riggs Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 11 2024
BUY
Open market or private purchase
$10,000 $2.95 p/Share
3,390 Added 49.17%
3,505 Common Stock, No Par V...
JR

Josh Riggs

CEO and President
Irvine, CA

Track Institutional and Insider Activities on OCX

Follow Oncocyte Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCX shares.

Notify only if

Insider Trading

Get notified when an Oncocyte Corp insider buys or sells OCX shares.

Notify only if

News

Receive news related to Oncocyte Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCX